CN111372936A - Mcl-1选择性抑制剂及其制备和用途 - Google Patents
Mcl-1选择性抑制剂及其制备和用途 Download PDFInfo
- Publication number
- CN111372936A CN111372936A CN201880075917.4A CN201880075917A CN111372936A CN 111372936 A CN111372936 A CN 111372936A CN 201880075917 A CN201880075917 A CN 201880075917A CN 111372936 A CN111372936 A CN 111372936A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- phenyl
- methyl
- substituted
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了Mcl‑1选择性抑制剂及其制备和用途;本发明同时提供了一系列由通式(I)所表示的化合物及其药学上可接受的盐、溶剂化物、多晶型物或前药、包含这些化合物的药物组合物,以及用此类化合物治疗由过度表达或失调的MCL‑1蛋白引起的或加重的疾病的方法。
Description
PCT国内申请,说明书已公开。
Claims (10)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711189194.4A CN109824690A (zh) | 2017-11-23 | 2017-11-23 | Mcl-1选择性抑制剂及其制备和用途 |
CN2017111891944 | 2017-11-23 | ||
CN2018104257840 | 2018-05-08 | ||
CN201810425784.0A CN110452253A (zh) | 2018-05-08 | 2018-05-08 | Mcl-1选择性抑制剂及其制备和用途 |
PCT/CN2018/117014 WO2019101144A1 (zh) | 2017-11-23 | 2018-11-22 | Mcl-1选择性抑制剂及其制备和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111372936A true CN111372936A (zh) | 2020-07-03 |
CN111372936B CN111372936B (zh) | 2022-12-02 |
Family
ID=66631350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880075917.4A Active CN111372936B (zh) | 2017-11-23 | 2018-11-22 | Mcl-1选择性抑制剂及其制备和用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111372936B (zh) |
WO (1) | WO2019101144A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113024577B (zh) * | 2019-12-09 | 2023-06-30 | 首药控股(北京)股份有限公司 | 一种抗凋亡蛋白选择性抑制剂的制备方法 |
CN113024578A (zh) * | 2019-12-09 | 2021-06-25 | 首药控股(北京)有限公司 | 一种mcl1选择性抑制剂的多晶型物及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015097123A1 (en) * | 2013-12-23 | 2015-07-02 | Les Laboratoires Servier | New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207217A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207225A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207216A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them |
CN108424417A (zh) * | 2017-12-21 | 2018-08-21 | 河南美泰宝生物制药有限公司 | 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用 |
CN109824690A (zh) * | 2017-11-23 | 2019-05-31 | 北京赛林泰医药技术有限公司 | Mcl-1选择性抑制剂及其制备和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3567043B1 (en) * | 2017-01-05 | 2023-12-06 | Henan Genuine Biotech Co., Ltd. | 2-[[5-[(4-hydroxy-3-chloro-2-methyl)-phenyl]-thieno[2,3-d]pyrimidin-4-yl]oxy]-3-(2-methoxybenzene)propanoic acid derivatives as mcl-1 and bcl-2 inhibitors for treating cancer |
-
2018
- 2018-11-22 CN CN201880075917.4A patent/CN111372936B/zh active Active
- 2018-11-22 WO PCT/CN2018/117014 patent/WO2019101144A1/zh active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015097123A1 (en) * | 2013-12-23 | 2015-07-02 | Les Laboratoires Servier | New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207217A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207225A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them |
WO2016207216A1 (en) * | 2015-06-23 | 2016-12-29 | Les Laboratoires Servier | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them |
CN109824690A (zh) * | 2017-11-23 | 2019-05-31 | 北京赛林泰医药技术有限公司 | Mcl-1选择性抑制剂及其制备和用途 |
CN108424417A (zh) * | 2017-12-21 | 2018-08-21 | 河南美泰宝生物制药有限公司 | 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN111372936B (zh) | 2022-12-02 |
WO2019101144A1 (zh) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20210089195A (ko) | 비페닐계 화합물, 이의 중간체, 제조 방법, 약학 조성물 및 용도 | |
CA2894130A1 (en) | Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof | |
JP6866967B2 (ja) | サイクリン依存性キナーゼcdk9の新規阻害剤 | |
BR112016008849B1 (pt) | Compostos ou sais farmaceuticamente aceitáveis dos mesmos, uso dos referidos compostos e composições farmacêuticas reivindicação de prioridade | |
KR20150119201A (ko) | 메틸 변형 효소 조절제, 이의 조성물 및 용도 | |
RU2600928C2 (ru) | Цианохинолиновые производные | |
CN109641897B (zh) | Bcl-2选择性抑制剂及其制备和用途 | |
TW202019913A (zh) | 細胞壞死抑制劑及其製備方法和用途 | |
CN113330009B (zh) | 氮杂环化合物、其制备方法及用途 | |
JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
CN103534240A (zh) | 选择性fak抑制剂 | |
TW201800413A (zh) | 作為jak抑制劑的吡咯並嘧啶化合物的結晶 | |
CN114206861A (zh) | 用作ripk1抑制剂的稠环杂芳基化合物 | |
WO2010037210A1 (en) | Viral polymerase inhibitors | |
WO2019120276A1 (zh) | 嘧啶酮化合物及其应用 | |
CN111372936B (zh) | Mcl-1选择性抑制剂及其制备和用途 | |
CN115073469A (zh) | 吡咯并嘧啶类化合物作为激酶抑制剂的制备及其应用 | |
KR20220021319A (ko) | 신규한 디옥솔로이소퀴놀린온 유도체 화합물 및 이의 용도 | |
CN104557871A (zh) | 具有螺环取代基的芳基吗啉类化合物,其制备方法和用途 | |
JP2022530866A (ja) | Prc2阻害剤としてのナフチリジン誘導体 | |
WO2016023330A1 (zh) | 喹唑啉衍生物 | |
CN110691775A (zh) | 一种具有fgfr4抑制活性的醛基吡啶衍生物、其制备方法和应用 | |
CN109790160A (zh) | 吡啶并五元芳香环类化合物、其制备方法及用途 | |
CN109824690A (zh) | Mcl-1选择性抑制剂及其制备和用途 | |
WO2019196720A1 (zh) | 一类精氨酸甲基转移酶抑制剂及其药物组合物和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |